CAS: 1361227-90-8
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | JH-RE-06 REF: TM-T15611CAS: 1361227-90-8 | 99.24% | 268,00 €~1.803,00 € | Vie 03 May 24 |
 | JH-RE-06 REF: 3D-LEC22790CAS: 1361227-90-8 | Min. 95% | A consultar | Vie 14 Jun 24 |
JH-RE-06
CAS:1361227-90-8
JH-RE-06 disrupts mutagenic translesion synthesis (TLS) by preventing the recruitment of mutagenic POLζ. JH-RE-06 is …
Fórmula:
C20H16Cl3N3O4
Pureza:
99.24%
Forma y color:
Solid
Peso molecular:
468.72
Ref: TM-T15611
| 1mg | 268,00 € | |
| 5mg | 433,00 € | |
| 10mg | 632,00 € | |
| 25mg | 994,00 € | |
| 50mg | 1.328,00 € | |
| 100mg | 1.803,00 € | |
| 1ml*10 (DMSO) | 430,00 € |
Entrega estimada en Estados Unidos, el Viernes 3 de Mayo de 2024
JH-RE-06
CAS:1361227-90-8
JH-RE-06 is a drug that can be used to treat cancer. It is an inhibitor …
Fórmula:
C20H16Cl3N3O4
Pureza:
Min. 95%
Peso molecular:
468.72 g/mol
Ref: 3D-LEC22790
| 1mg | A consultar | |
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar |
Entrega estimada en Estados Unidos, el Viernes 14 de Junio de 2024
